[1]赵若寒 罗素新 熊峰 李袁静 黄龙祥.心力衰竭并发复杂性室性心律失常相关因素分析[J].心血管病学进展,2020,(7):782-786.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.025]
　ZHAO Ruohan,LUO Suxin,XIONG Feng,et al.Analysis of Related Factors of Heart Failure Accompany?span style="">with Complex Ventricular Arrythmia[J].Advances in Cardiovascular Diseases,2020,(7):782-786.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.025]
点击复制

心力衰竭并发复杂性室性心律失常相关因素分析()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年7期
页码:
782-786
栏目:
出版日期:
2020-07-25

文章信息/Info

Title:
Analysis of Related Factors of Heart Failure Accompany?span style="">with Complex Ventricular Arrythmia
作者:
赵若寒 罗素新 熊峰 李袁静 黄龙祥
(1.成都市第三人民医院心血管内科,四川 成都 610031;2.重庆医科大学附属第一医院心血管内科,重庆400010)
Author(s):
Verdana;  sans-serif; COLOR: #666666; BACKGROUND-COLOR: rgb(255; 255; 255)">ZHAO Ruohan; LUO Suxin;  XIONG Feng; LI Yuanjing;  HUANG Longxiang
1.Department of Cardiology, The Third Peoples Hospital of Chengdu,Chengdu 610031,Sichuan, China2.Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
关键词:
心力衰竭; 室性心律失常; 相关因素
Keywords:
Heart failure; Ventricular arrythmia; Related factor
DOI:
10.16806/j.cnki.issn.1004-3934.2020.07.025
摘要:
室性心律失常的相关因素。方法 收集心力衰竭患者519例，根据24小时动态心电图结果，将LOWN分级1～2级患者纳入Ⅰ组（共284例），LOWN分级3～5级患者纳入Ⅱ组（共235例），利用单因素及多因素回归，回顾性分析心力衰竭患者一般资料及相关实验室结果等指标与复杂性室性心律失常发生的相关性。结果 心力衰竭患者发生复杂性室性心律失常的独立相关因素为体重指数≥24 kg/m2（OR 1.727，95% CI 1.139～2.619）、舒张压下降（OR 0.987，95% CI 0.974～1.0）、左室舒张末径增加（OR 1.064，95% CI 1.033～1.097）、左室射血分数下降（OR 0.973，95% CI 0.949～0.999）、β受体阻滞剂使用（OR 1.883，95% CI 1.175～3.019）及西地兰使用（OR 9.788，95% CI 2.094～45.739），P＜0.05。结论 超重、左室舒张末期内径增加及左室射血分数下降是心力衰竭患者发生复杂性室性心律失常的独立相关因素，应注重心力衰竭患者的体重管理。在心力衰竭合并复杂性室性心律失常患者的随访中，血压监测、24小时动态心电图和超声心动图是有必要的。西地兰和β受体阻滞剂通常被用于心力衰竭合并复杂性室性心律失常。
Abstract:
Objective To explore the related factors of complex ventricular arrythmia in heart failure patients. Methods We retrospectively analyzed 519 chronic heart failure patients who hospitalized at The First Affiliated Hospital of Chongqing Medical University. The patients were divided into Group I(n=284) and Group Ⅱ(n=235) according to the 24-hour ambulatory electrocardiogram by the LOWN classification. The general information, laboratory data etc. were analyzed. Results Independent related factors of complex ventricular arrythmia in heart failure patients are BMI≥24 kg/m2（OR 1.727，95% CI 1.139～2.619）, decreased diastolic blood pressure（OR 0.987，95% CI 0.974～1.0）, increased left ventricular end diastolic diameter（OR 1.064，95% CI 1.033～1.097）, decreased LVEF（OR 0.973，95% CI 0.949～0.999, the use of β-blocker（OR 1.883，95% CI 1.175～3.019）and the use of Cedilanid（OR 9.788，95% CI 2.094～45.739），P＜0.05.Conclusion BMI≥24 kg/m2, decreased diastolic blood pressure, increased left ventricular end diastolic diameter and decreased LVEF are independent related factors of complex ventricular arrythmia in heart failure patients. Attention should be paid to weight management in heart failure patients。Meanwhile，follow-up of blood pressure，24 h ambulatory ECG and echocardiography for heart failure patients with complex ventricular arrhythmia are necessary. The Cedilanid and β-blocker are frequently implied to control ventricular arrhythmia in heart failure patients

相似文献/References:

[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
　DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(7):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
　LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(7):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
　ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(7):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
　LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(7):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
　KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(7):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
　SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(7):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]张耀庭 李烽 朱永翔 陆丽洁 龙明智.沙库巴曲/缬沙坦在室性心律失常中的研究进展[J].心血管病学进展,2019,(7):982.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.004]
　ZHANG Yaoting,LI Feng,ZHU Yongxiang,et al.Research Progress of Sacubitril/Valsartan in Ventricular Arrhythmia[J].Advances in Cardiovascular Diseases,2019,(7):982.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.004]
[8]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
　XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(7):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[9]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
　GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(7):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[10]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
　HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(7):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]

备注/Memo

备注/Memo:
基金项目：国家临床重点专科建设项目（财社【2011】170号）；国家自然科学基金（81270210）收稿日期：2019-01-06
更新日期/Last Update: 2020-10-10